Skip to main content

Table 1 Choice of antibiotics based on antibiotics sensitivity studies

From: Preserving brain function in a comatose patient with septic hyperpyrexia (41.6 °C): a case report

Day

WBC count (Range)

Temperature maximum

Antibiotic regimen based on culture and sensitivity studies

Microorganism

1–7

11.9–18.6

37.1 °C (98.7 °F)

Piperacillin-tazobactam 3.375 g intravenously Q 8 hours. Vancomycin 1 g intravenously Q 12 hours

K. pneumoniae – sputum

8–13

10.6–29.5

41.6 °C (106.9 °F)

Levofloxacin 500 mg intravenously Q 48 hours. Micafungin 100 mg intravenously Q daily

K. pneumoniae – sputum. C. albicans – blood

14–22

9.1–22.1

38.9 °C (102 °F)

Levofloxacin 500 mg intravenously Q 48 hours

C. albicans – blood and sputum

23–30

12.1–20.9

39.7 °C (103.4 °F)

Fluconazole 100 mg/50 ml, 100 mg Q 24 hours

C. albicans – blood

31–41

13.9–29.7

36.7–39.4 °C (98–103 °F)

Levofloxacin 500 mg intravenously Q 48 hours. Piperacillin-tazobactam 3.375 g intravenously Q 8 hours

P. aeruginosa – stool and wound

42–49

12.6–17.5

36.7–39.4 °C (98–103 °F)

Daptomycin 500 mg intravenously Q 8 hours

S. epidermidis – skin, stool, blood

50–57

7.2–17.5

36.8–39.4 °C (98.3–102.9 °F)

Metronidazole 500 mg intravenously Q 8 hours. Linezolid 600 mg/300 ml Q 12 hours

MRSA – sputum. C. difficile – stool

58–67

10.1–15.9

36.5–37.6 °C (97.7–99.7 °F)

Levofloxacin 750 mg intravenously Q 24 hours. Daptomycin 500 mg intravenously Q 8 hours

MRSA – sputum

68–78

7.3–18.2

36.5–39.0 °C (97.7–102.2 °F)

Vancomycin 1 g intravenously Q 12 hours. Imipenem 500 mg intravenously Q 8 hours

MRSA – Blood

  1. C. albicans Candida albicans, C. difficile Clostridium difficile, K. pneumonia Klebsiella pneumoniae, MRSA methicillin-resistant Staphylococcus aureus, P. aeruginosa Pseudomonas aeruginosa, Q every, S. epidermidis Staphylococcus epidermidis, WBC white blood cells